Angel Varela‐Rohena

2.7k total citations · 1 hit paper
12 papers, 1.6k citations indexed

About

Angel Varela‐Rohena is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Angel Varela‐Rohena has authored 12 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Angel Varela‐Rohena's work include CAR-T cell therapy research (5 papers), Virus-based gene therapy research (4 papers) and T-cell and B-cell Immunology (4 papers). Angel Varela‐Rohena is often cited by papers focused on CAR-T cell therapy research (5 papers), Virus-based gene therapy research (4 papers) and T-cell and B-cell Immunology (4 papers). Angel Varela‐Rohena collaborates with scholars based in United States, United Kingdom and Norway. Angel Varela‐Rohena's co-authors include James L. Riley, Carl H. June, Richard G. Carroll, Megan M. Suhoski, Michael C. Milone, Carmine Carpenito, Daniel F. Heitjan, Jacqueline C. Simonet, Kathleen M. Haines and Ira Pastan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Science Translational Medicine.

In The Last Decade

Angel Varela‐Rohena

11 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains

2009 690 citations Carmine Carpenito, Michael C. Milone et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angel Varela‐Rohena United States	9	1.1k	835	395	381	251	12	1.6k
Amy N. Courtney United States	19	1.1k 1.0×	1.0k 1.2×	254 0.6×	322 0.8×	218 0.9×	38	1.7k
Martin Andreánsky United States	11	654 0.6×	287 0.3×	239 0.6×	265 0.7×	203 0.8×	21	1.0k
Wenbo Yu Australia	17	507 0.5×	340 0.4×	190 0.5×	293 0.8×	177 0.7×	31	941
Victoria Shi United States	12	671 0.6×	323 0.4×	159 0.4×	341 0.9×	174 0.7×	23	1.1k
Blythe Sather United States	19	733 0.7×	1.1k 1.3×	442 1.1×	671 1.8×	135 0.5×	29	2.0k
Franziska Blaeschke Germany	18	832 0.7×	449 0.5×	288 0.7×	658 1.7×	165 0.7×	33	1.4k
Gwendolyn Binder-Scholl United States	7	761 0.7×	340 0.4×	658 1.7×	1.1k 2.8×	174 0.7×	11	1.7k
Alana A. Kennedy‐Nasser United States	13	1.3k 1.2×	757 0.9×	669 1.7×	517 1.4×	277 1.1×	23	2.1k
Veit R. Buchholz Germany	19	799 0.7×	2.2k 2.6×	177 0.4×	569 1.5×	169 0.7×	33	2.7k
Federico Simonetta Switzerland	22	562 0.5×	945 1.1×	132 0.3×	268 0.7×	99 0.4×	82	1.5k

Countries citing papers authored by Angel Varela‐Rohena

Since Specialization

Citations

This map shows the geographic impact of Angel Varela‐Rohena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angel Varela‐Rohena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angel Varela‐Rohena more than expected).

Fields of papers citing papers by Angel Varela‐Rohena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angel Varela‐Rohena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angel Varela‐Rohena. The network helps show where Angel Varela‐Rohena may publish in the future.

Co-authorship network of co-authors of Angel Varela‐Rohena

This figure shows the co-authorship network connecting the top 25 collaborators of Angel Varela‐Rohena. A scholar is included among the top collaborators of Angel Varela‐Rohena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angel Varela‐Rohena. Angel Varela‐Rohena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Guo, Lili, Luis Gil‐de‐Gómez, Andrew Medvec, et al.. (2018). Differential Reliance on Lipid Metabolism as a Salvage Pathway Underlies Functional Differences of T Cell Subsets in Poor Nutrient Environments. Cell Reports. 23(3). 741–755. 47 indexed citations

Medvec, Andrew, et al.. (2017). Improved Expansion and In Vivo Function of Patient T Cells by a Serum-free Medium. Molecular Therapy — Methods & Clinical Development. 8. 65–74. 45 indexed citations

Zhang, Hui, et al.. (2017). New dynabeads™treg CD3/CD28 and animal origin-free, serum-free media for regulatory T cell activation and expansion to be used in clinical applications. Cytotherapy. 19(5). e6–e6. 1 indexed citations

Schageman, Jeoffrey, et al.. (2013). Profiling of glycosylation gene expression in CHO fed-batch cultures in response to glycosylation-enhancing medium components. BMC Proceedings. 7(S6). 1 indexed citations

Francica, Joseph R., Angel Varela‐Rohena, Andrew Medvec, et al.. (2010). Steric Shielding of Surface Epitopes and Impaired Immune Recognition Induced by the Ebola Virus Glycoprotein. PLoS Pathogens. 6(9). e1001098–e1001098. 120 indexed citations

Paulos, Chrystal M., Carmine Carpenito, Gabriela Plesa, et al.. (2010). The Inducible Costimulator (ICOS) Is Critical for the Development of Human T _H 17 Cells. Science Translational Medicine. 2(55). 55ra78–55ra78. 204 indexed citations

Varela‐Rohena, Angel, Bent K. Jakobsen, Andrew K. Sewell, Carl H. June, & James L. Riley. (2009). Are Affinity-Enhanced T Cells the Future of HIV Therapy?. 3(2). 105–108. 2 indexed citations

Carpenito, Carmine, Michael C. Milone, Raffit Hassan, et al.. (2009). Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proceedings of the National Academy of Sciences. 106(9). 3360–3365. 690 indexed citations breakdown →

Varela‐Rohena, Angel, Peter Molloy, Steven M. Dunn, et al.. (2008). Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nature Medicine. 14(12). 1390–1395. 197 indexed citations

10.

Varela‐Rohena, Angel, Carmine Carpenito, Elena Pérez, et al.. (2008). Genetic engineering of T cells for adoptive immunotherapy. Immunologic Research. 42(1-3). 166–181. 51 indexed citations

11.

Suhoski, Megan M., Tatiana N. Golovina, Nicole A. Aqui, et al.. (2007). Engineering Artificial Antigen-presenting Cells to Express a Diverse Array of Co-stimulatory Molecules. Molecular Therapy. 15(5). 981–988. 208 indexed citations

12.

Martín‐García, Julio, Wei Cao, Angel Varela‐Rohena, Matthew Plassmeyer, & Francisco González‐Scarano. (2005). HIV-1 tropism for the central nervous system: Brain-derived envelope glycoproteins with lower CD4 dependence and reduced sensitivity to a fusion inhibitor. Virology. 346(1). 169–179. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact